Michael Hunkapiller's Insider Trades & SAST Disclosures
Michael Hunkapiller's most recent trade in Pacific Biosciences of California Inc was a trade of 170,824 Common Stock done at an average price of $30.7 . Disclosure was reported to the exchange on Feb. 26, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Hunkapiller.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 30.69 per share. | 26 Feb 2021 | 170,824 | 911,827 (0%) | 0% | 30.7 | 5,242,076 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 109,749 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.72 per share. | 26 Feb 2021 | 109,749 | 958,154 (0%) | 0% | 5.7 | 627,764 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 79,363 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. | 26 Feb 2021 | 79,363 | 1,037,517 (0%) | 0% | 7.9 | 624,587 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2021 | 45,134 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.27 per share. | 26 Feb 2021 | 45,134 | 1,082,651 (0%) | 0% | 5.3 | 237,856 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 31.49 per share. | 26 Feb 2021 | 43,946 | 867,881 (0%) | 0% | 31.5 | 1,383,991 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 32.74 per share. | 26 Feb 2021 | 15,771 | 852,110 (0%) | 0% | 32.7 | 516,311 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 26 Feb 2021 | 3,705 | 848,405 (0%) | 0% | 33.3 | 123,488 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 135,882 | 79,363 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. | 24 Feb 2021 | 135,882 | 1,052,023 (0%) | 0% | 7.9 | 1,069,391 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 135,759 | 45,134 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.27 per share. | 24 Feb 2021 | 135,759 | 1,187,782 (0%) | 0% | 5.3 | 715,450 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 31.97 per share. | 24 Feb 2021 | 123,383 | 953,884 (0%) | 0% | 32.0 | 3,944,678 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 31.04 per share. | 24 Feb 2021 | 110,515 | 1,077,267 (0%) | 0% | 31.0 | 3,430,938 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.72 per share. | 24 Feb 2021 | 90,560 | 974,692 (0%) | 0% | 5.7 | 518,003 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 90,560 | 177,485 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 87,374 | 180,893 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.27 per share. | 24 Feb 2021 | 87,374 | 1,114,832 (0%) | 0% | 5.3 | 460,461 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 35.59 per share. | 24 Feb 2021 | 87,349 | 1,027,483 (0%) | 0% | 35.6 | 3,108,402 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 37.47 per share. | 24 Feb 2021 | 72,303 | 899,781 (0%) | 0% | 37.5 | 2,708,904 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 67,736 | 109,749 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.72 per share. | 24 Feb 2021 | 67,736 | 916,141 (0%) | 0% | 5.7 | 387,450 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 36.41 per share. | 24 Feb 2021 | 55,399 | 972,084 (0%) | 0% | 36.4 | 2,017,244 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 52,766 | 215,245 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. | 24 Feb 2021 | 52,766 | 1,027,458 (0%) | 0% | 7.9 | 415,268 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 38.36 per share. | 24 Feb 2021 | 51,376 | 848,405 (0%) | 0% | 38.4 | 1,970,732 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 34.21 per share. | 24 Feb 2021 | 49,410 | 881,143 (0%) | 0% | 34.2 | 1,690,267 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 35,727 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.14 per share. | 24 Feb 2021 | 35,727 | 884,132 (0%) | 0% | 6.1 | 219,364 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 34.73 per share. | 24 Feb 2021 | 29,500 | 851,643 (0%) | 0% | 34.7 | 1,024,476 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 32.88 per share. | 24 Feb 2021 | 23,331 | 930,553 (0%) | 0% | 32.9 | 767,053 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 35.68 per share. | 24 Feb 2021 | 3,238 | 848,405 (0%) | 0% | 35.7 | 115,532 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 35.10 per share. | 22 Feb 2021 | 113,308 | 995,086 (0%) | 0% | 35.1 | 3,977,224 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.14 per share. | 22 Feb 2021 | 86,084 | 934,489 (0%) | 0% | 6.1 | 528,556 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 86,084 | 35,727 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.72 per share. | 22 Feb 2021 | 86,065 | 1,020,554 (0%) | 0% | 5.7 | 492,292 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 86,065 | 268,045 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.27 per share. | 22 Feb 2021 | 86,047 | 1,192,623 (0%) | 0% | 5.3 | 453,468 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 86,047 | 268,267 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. | 22 Feb 2021 | 86,022 | 1,106,576 (0%) | 0% | 7.9 | 676,993 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 86,022 | 268,011 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 35.99 per share. | 22 Feb 2021 | 74,119 | 920,967 (0%) | 0% | 36.0 | 2,667,691 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 36.85 per share. | 22 Feb 2021 | 72,562 | 848,405 (0%) | 0% | 36.8 | 2,673,692 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 40.28 per share. | 22 Feb 2021 | 57,902 | 890,519 (0%) | 0% | 40.3 | 2,332,524 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 37.17 per share. | 22 Feb 2021 | 57,260 | 1,020,272 (0%) | 0% | 37.2 | 2,128,469 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. | 22 Feb 2021 | 45,967 | 985,951 (0%) | 0% | 7.9 | 361,760 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 45,967 | 354,033 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 22 Feb 2021 | 45,895 | 1,077,532 (0%) | 0% | 2.6 | 120,704 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 45,895 | 54,105 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 45,890 | 354,110 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.72 per share. | 22 Feb 2021 | 45,890 | 939,984 (0%) | 0% | 5.7 | 262,491 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.14 per share. | 22 Feb 2021 | 45,689 | 894,094 (0%) | 0% | 6.1 | 280,530 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 45,689 | 121,811 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.27 per share. | 22 Feb 2021 | 45,686 | 1,031,637 (0%) | 0% | 5.3 | 240,765 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 45,686 | 354,314 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 34.22 per share. | 22 Feb 2021 | 42,378 | 1,108,394 (0%) | 0% | 34.2 | 1,450,345 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 41.06 per share. | 22 Feb 2021 | 42,114 | 848,405 (0%) | 0% | 41.1 | 1,729,369 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 39.15 per share. | 22 Feb 2021 | 38,360 | 948,421 (0%) | 0% | 39.1 | 1,501,641 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 38.08 per share. | 22 Feb 2021 | 33,491 | 986,781 (0%) | 0% | 38.1 | 1,275,404 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 22 Feb 2021 | 29,103 | 1,221,726 (0%) | 0% | 2.6 | 76,541 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2021 | 29,103 | 25,002 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 31.71 per share. | 22 Feb 2021 | 28,595 | 1,169,031 (0%) | 0% | 31.7 | 906,633 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 30.90 per share. | 22 Feb 2021 | 24,100 | 1,197,626 (0%) | 0% | 30.9 | 744,642 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 22 Feb 2021 | 18,259 | 1,150,772 (0%) | 0% | 33.0 | 602,091 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.14 per share. | 25 Jan 2021 | 125,406 | 973,811 (0%) | 0% | 6.1 | 769,993 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 125,406 | 167,500 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 36.01 per share. | 25 Jan 2021 | 83,241 | 885,403 (0%) | 0% | 36.0 | 2,997,175 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 37.17 per share. | 25 Jan 2021 | 32,082 | 853,321 (0%) | 0% | 37.2 | 1,192,360 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 35.17 per share. | 25 Jan 2021 | 5,167 | 968,644 (0%) | 0% | 35.2 | 181,708 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 37.77 per share. | 25 Jan 2021 | 4,916 | 848,405 (0%) | 0% | 37.8 | 185,658 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 215,026 | 152,474 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 20 Jan 2021 | 215,026 | 1,113,241 (0%) | 0% | 2.3 | 488,109 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 20 Jan 2021 | 152,474 | 1,050,689 (0%) | 0% | 2.3 | 346,116 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 152,474 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.14 per share. | 20 Jan 2021 | 150,857 | 999,262 (0%) | 0% | 6.1 | 926,262 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 150,857 | 292,906 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 38.79 per share. | 20 Jan 2021 | 141,199 | 972,042 (0%) | 0% | 38.8 | 5,476,968 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 36.39 per share. | 20 Jan 2021 | 113,472 | 964,405 (0%) | 0% | 36.4 | 4,129,473 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 36.95 per share. | 20 Jan 2021 | 70,377 | 883,720 (0%) | 0% | 36.9 | 2,600,289 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 37.18 per share. | 20 Jan 2021 | 61,834 | 902,571 (0%) | 0% | 37.2 | 2,298,988 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.14 per share. | 20 Jan 2021 | 56,237 | 1,106,926 (0%) | 0% | 6.1 | 345,295 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2021 | 56,237 | 443,763 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 35.92 per share. | 20 Jan 2021 | 45,165 | 954,097 (0%) | 0% | 35.9 | 1,622,146 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 39.35 per share. | 20 Jan 2021 | 43,846 | 928,196 (0%) | 0% | 39.3 | 1,725,121 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 37.52 per share. | 20 Jan 2021 | 35,315 | 848,405 (0%) | 0% | 37.5 | 1,325,054 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 35.44 per share. | 20 Jan 2021 | 29,049 | 1,077,877 (0%) | 0% | 35.4 | 1,029,380 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 37.13 per share. | 20 Jan 2021 | 25,993 | 848,405 (0%) | 0% | 37.1 | 965,068 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 40.69 per share. | 20 Jan 2021 | 24,032 | 904,164 (0%) | 0% | 40.7 | 977,862 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 36.30 per share. | 20 Jan 2021 | 23,817 | 874,398 (0%) | 0% | 36.3 | 864,629 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 41.40 per share. | 20 Jan 2021 | 5,949 | 898,215 (0%) | 0% | 41.4 | 246,318 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 39.09 per share. | 20 Jan 2021 | 3,656 | 898,215 (0%) | 0% | 39.1 | 142,895 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 38.06 per share. | 20 Jan 2021 | 700 | 901,871 (0%) | 0% | 38.1 | 26,639 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 364,451 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.01 per share. | 21 Dec 2020 | 364,451 | 1,262,666 (0%) | 0% | 3.0 | 1,096,998 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 23.29 per share. | 21 Dec 2020 | 243,544 | 906,729 (0%) | 0% | 23.3 | 5,671,409 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 187,500 | 367,500 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 21 Dec 2020 | 187,500 | 1,233,764 (0%) | 0% | 2.3 | 425,625 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Sale of securities on an exchange or to another person at price $ 25.41 per share. | 21 Dec 2020 | 172,242 | 1,026,229 (0%) | 0% | 25.4 | 4,377,014 | Common Stock |
| Pacific Biosciences of Cal... | Michael Hunkapiller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 135,549 | 364,451 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges